Chk‐1 inhibitors such as rabusertib increased the cytotoxicity of etoposide/carboplatin when applied in simultaneous combination to the SCLC lines in an additive to greater than additive manner (Fig. 5A). The gene discussed is CHEK1; the disease is small cell lung carcinoma.